Navigation Links
The right messenger for a healthy immune response
Date:7/20/2009

Researchers from the Molecular Immunology group at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany have now shown that Beta-Interferon also plays a crucial role during an immune response: without Beta-Interferon immune cells are unable to show "wanted posters" of pathogens to other cells. As a consequence, these cells will not recognize the pathogen and the immune response does not start properly. The group's results have now been published in the current issue of the scientific magazine Journal of Immunology.

During an infection, immune cells produce Beta-Inferferon. Interestingly, an immune response is even stronger when a low amount of Beta-Interferon has already been present before the infection occurs. Scientists call this behaviour "priming". A healthy basal level of Beta-Interferon facilitates a faster immune reaction against microbial and viral threads.

Researchers from the HZI have now managed to show why this is the case: Beta-Interferon is a key regulator and of vital importance in enabling the immune system to display fragments of pathogens, so-called antigens. Immune cells present these antigens on their surface and in this way communicate with one another: antigens are the "wanted posters" of the virus or the bacterium which has to be destroyed.

The researchers discovered the important role of Beta-Interferon in mice lacking the gene for Beta-Interferon. These mice displayed poor immune responses. "Without those knock-out mice we would not have been able to identify the impact of Beta-Interferon on the immune system," says Siegfried Wei, leader of the Molecular Immunology group at the HZI. His research assistant, the scientist Natalia Zietara, investigated what Beta-Interferon is doing in immune cells. She found a molecular factor that is pivotal in producing the pathogen's profile and which is regulated by Beta-Interferon. The factor belongs to a group of proteins that is usually produced in conditions of stress. Without Beta-Interferon, no active stress protein without stress protein, no wanted poster without wanted poster, no immune response.

"We now have a far better understanding of how immune responses start, but also how diseases like autoimmune diseases may develop," says Wei: without Beta-Interferon, the immune system may not be able to learn how to tolerate itself during the embryonic phase and that it should not fight against self-structures. "Our findings can help to develop or improve new therapeutics to combat autoimmune diseases such as multiple sclerosis or cancer."


'/>"/>

Contact: Hannes Schlender
hannes.schlender@helmholtz-hzi.de
49-053-161-811-402
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. Why the thumb of the right hand is on the left hand side
2. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
3. WPI professor receives Fulbright Scholarship to work on tissue engineering in Ireland
4. Study: Health undervalued in reproductive rights debate
5. Female mammals follow their noses to the right mates
6. Right whale sedation enables disentanglement effort
7. High numbers of right whales seen in Gulf of Maine
8. Bright lights, not-so-big pupils
9. Snails and humans use same genes to tell right from left
10. Disability Rights Legal Center honors Ossur
11. Physical activity and health: Finding the right prescription
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... ... August 17, 2017 , ... ... market news outlet had provided a research update on Aytu Bioscience and cited ... product. , According to Soulstring, prescription rates for Natesto® have more than doubled ...
(Date:8/16/2017)... Prussia, PA (PRWEB) , ... August 16, 2017 , ... ... be taking part in sessions at the ISPE Annual Meeting and Expo , ... Marquis San Diego Marina. The event’s theme is “Driving innovation to advance patient therapies.” ...
(Date:8/16/2017)... ... August 16, 2017 , ... Recent studies show that ... treatments for specific cancers, such as breast, prostate, or lung, target vital pathways ... therapy for advanced prostate cancer. , This therapy limits the production and ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar Biologics ... secured $2M in funding from an impressive group of investors, including Rev1 Ventures, ... Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering that ...
Breaking Biology Technology: